Rchr
J-GLOBAL ID：200901007697296886   Update date: Jul. 16, 2024

Tohyama Yumi

トオヤマ ユミ | Tohyama Yumi
Affiliation and department：
Himeji Dokkyo University Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Health Care

About Himeji Dokkyo University Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Health Care


Research field  (2)： Immunology ,  Pathobiochemistry
Research keywords  (2)： 免疫学 ,  生化学
Research theme for competitive and other funds  (14)：
  • 2021 - 2024 Development of novel therapy for thrombosis induced by neutrophil extracellular traps
  • 2020 - 2023 モデル細胞株を活用した骨髄異形成症候群の白血病化を阻止する戦略
  • 2018 - 2021 Development of early diagnosis of thrombosis induced by neutrophil extracellular traps
  • 2014 - 2017 Elucidation of the molecular mechanisms of neutrophil extracellular traps (NETs) formation
  • 2011 - 2013 Investigation of the molecular mechanism of osteoclast function
Show all
Papers (38)：
  • Hiroyuki Tabata, Hiroyuki Morita, Kenichi Kouyama, Yumi Tohyama. Complement dependent TNFα production in neutrophil-like HL60 cells. Biochemistry and Biophysics Reports. 2023. 34. 101465-101465
  • Hiroyuki Tabata, Hiroyuki Morita, Hiroaki Kaji, Kaoru Tohyama, Yumi Tohyama. Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling in complement-mediated phagocytosis. Scientific Reports. 2020. 10. 1
  • Morita H, Matsuoka A, Kida JI, Tabata H, Tohyama K, Tohyama Y. KIF20A, highly expressed in immature hematopoietic cells, supports the growth of HL60 cell line. International journal of hematology. 2018. 108. 6. 607-614
  • Kida JI, Tsujioka T, Suemori SI, Okamoto S, Sakakibara K, Takahata T, Yamauchi T, Kitanaka A, Tohyama Y, Tohyama K. An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS. Leukemia. 2018. 32. 8. 1846-1850
  • Yuki Takechi-Haraya, Kenzo Aki, Yumi Tohyama, Yuichi Harano, Toru Kawakami, Hiroyuki Saito, Emiko Okamura. Glycosaminoglycan binding and non-endocytic membrane translocation of cell-permeable octaarginine monitored by real-time in-cell NMR spectroscopy. Pharmaceuticals. 2017. 10. 2
ｍore...
MISC (24)：
ｍore...
Education (2)：
  • - 1999 Kobe University
  • - 1983 Kyoto University Faculty of Pharmaceutical Sciences
Professional career (1)：
  • 博士(医学) (神戸大学)
Work history (1)：
  • 1983 - 〜85田辺製薬株式会社研究員、1999年〜2002京都大学大学院医学研究科分子免疫アレルギ-学勤務、02年〜神戸大学大学院医学系研究科機能ゲノム学COE 研究員、〜同助手、〜同助教授を経て06年姫路獨協大学新学部創設準備室教授、07年〜薬学部・医療薬学科・生化学教授 現在に至る
Committee career (1)：
  • 日本生化学会 評議員
Association Membership(s) (5)：
米国生化学・分子生物学会 ,  米国血液学会 ,  日本血液学会 ,  日本免疫学会 ,  日本生化学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM